{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:53:00Z","timestamp":1781765580240,"version":"3.54.5"},"reference-count":50,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Disease (NIAID)","award":["5SC2AI081656-02"],"award-info":[{"award-number":["5SC2AI081656-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Neisseria\u00a0gonorrhoeae is the third most common sexually transmitted infection (STI), which may become untreatable soon if resistance continues to drastically increase. Due to increases in resistance to recommended antibiotics, alternative sources of novel compounds to combat this threat are being explored. Interestingly, marine sponges have proven to produce a plethora of bioactive compounds that display anticancer, antiviral, antifungal, and antibacterial activity. Methods: In this study, the extracts of the sponge collected from Saint Thomas, US Virgin Islands were examined to determine their antibacterial activity against E. coli, S. aureus, and N. gonorrhoeae. Results: The ethyl acetate sponge extracts significantly inhibited growth of N. gonorrhoeae, while none inhibited S. aureus and E. coli. The bioassay-guided purification of the ethyl acetate extract resulted in the isolation of 6-desmethyl-6-ethylspongosoritin A (1) and plakortone B (2). To determine if the pure sponge metabolite could improve the efficacy of ceftriaxone against a high-level ceftriaxone (HTX)-resistant gonococcal strain, an antibiotic checkerboard assay was done by combining various concentrations of either precursor fractions or the purified compound 2 with ceftriaxone. Plakortone B (2) and ceftriaxone acted in synergy against gonococcal strains and inhibited growth by increasing membrane permeability when exposed for 4 h and 24 h. Conclusions: This suggests that marine sponges may serve as a source for novel bioactive compounds against antibiotic-resistant strains of N. gonorrhoeae, as well as improve the efficacy of currently prescribed antibiotics.<\/jats:p>","DOI":"10.3390\/antibiotics13121229","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:50:44Z","timestamp":1734591044000},"page":"1229","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bioactive Compounds Isolated from a Marine Sponge Selectively Inhibit Neisseria gonorrhoeae"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-6675","authenticated-orcid":false,"given":"Omar E.","family":"Christian","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, North Carolina Central University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dreyona A.","family":"Perry","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Biomedical Sciences, North Carolina Central University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa I.","family":"Telchy","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Biomedical Sciences, North Carolina Central University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston N.","family":"Walton","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Alabama State University, Montgomery, AL 36104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8512-0359","authenticated-orcid":false,"given":"Daniel","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Alabama State University, Montgomery, AL 36104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(97)02190-9","article-title":"Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0000000000000980","article-title":"Proportion of Incident Human Immunodeficiency Virus Cases Among Men Who Have Sex With Men Attributable to Gonorrhea and Chlamydia: A Modeling Analysis","volume":"46","author":"Jones","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref_3","unstructured":"Centers for Disease Control and Prevention (2024, June 27). Drug Resistant Neisseria gonorrhoeae, Available online: https:\/\/www.cdc.gov\/antimicrobial-resistance\/media\/pdfs\/gonorrhea-508.pdf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bjm.2017.06.001","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: History, molecular mechanisms and epidemiological aspects of an emerging global threat","volume":"48","author":"Moreira","year":"2017","journal-title":"Braz. J. Microbiol."},{"key":"ref_5","first-page":"419","article-title":"An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae","volume":"134","author":"Patel","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00007435-198810000-00006","article-title":"Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States","volume":"15","author":"Whittington","year":"1988","journal-title":"Sex. Transm. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/OLQ.0b013e3182631c9f","article-title":"Retrospective analysis of antimicrobial susceptibility trends (2000\u20132009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone","volume":"39","author":"Starnino","year":"2012","journal-title":"Sex. Transm. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/AAC.00093-13","article-title":"Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041","volume":"57","author":"Tomberg","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC) (2012). Update to CDC\u2019s Sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb. Mortal. Wkly. Rep., 61, 590\u2013594.","DOI":"10.1016\/j.annemergmed.2012.10.014"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/OLQ.0000000000001742","article-title":"Effectiveness of Cefixime for the Treatment of Neisseria gonorrhoeae Infection at 3 Anatomic Sites: A Systematic Review and Meta-Analysis","volume":"50","author":"Yang","year":"2023","journal-title":"Sex. Transm. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020","volume":"69","author":"Barbee","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3201\/eid2201.150868","article-title":"New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan","volume":"22","author":"Deguchi","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vincent, L.R., Kerr, S.R., Tan, Y., Tomberg, J., Raterman, E.L., Dunning Hotopp, J.C., Unemo, M., Nicholas, R.A., and Jerse, A.E. (2018). In Vivo-Selected Compensatory Mutations Restore the Fitness Cost of Mosaic penA Alleles That Confer Ceftriaxone Resistance in Neisseria gonorrhoeae. mBio, 9.","DOI":"10.1128\/mBio.01905-17"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/eva.12196","article-title":"The fitness costs of antibiotic resistance mutations","volume":"8","author":"Melnyk","year":"2015","journal-title":"Evol. Appl."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0035-1545721","article-title":"Antichlamydial sterol from the Red Sea sponge Callyspongia aff. implexa","volume":"81","author":"Abdelmohsen","year":"2015","journal-title":"Planta Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Barzkar, N., Sukhikh, S., and Babich, O. (2024). A comprehensive review of marine sponge metabolites, with emphasis on Neopetrosia sp.. Int. J. Biol. Macromol., 280.","DOI":"10.1016\/j.ijbiomac.2024.135823"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cbpc.2017.04.001","article-title":"Antibacterial and antibiotic potentiating activities of tropical marine sponge extracts","volume":"196","author":"Beesoo","year":"2017","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbagen.2017.08.014","article-title":"Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology","volume":"1862","author":"Gogineni","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.3390\/md12084539","article-title":"Marine sponge derived natural products between 2001 and 2010: Trends and opportunities for discovery of bioactives","volume":"12","author":"Mehbub","year":"2014","journal-title":"Mar. Drugs"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ijbiomac.2018.04.110","article-title":"Antibacterial macro molecules from marine organisms","volume":"115","author":"Nalini","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pech-Puch, D., Perez-Povedano, M., Gomez, P., Martinez-Guitian, M., Lasarte-Monterrubio, C., Vazquez-Ucha, J.C., Novoa-Olmedo, M.L., Guillen-Hernandez, S., Villegas-Hernandez, H., and Bou, G. (2020). Marine Organisms from the Yucatan Peninsula (Mexico) as a Potential Natural Source of Antibacterial Compounds. Mar. Drugs, 18.","DOI":"10.3390\/md18070369"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/np970215v","article-title":"The calyxolanes: New 1,3-diphenylbutanoid metabolites isolated from the Caribbean marine sponge Calyx podatypa","volume":"60","author":"Rodriguez","year":"1997","journal-title":"J. Nat. Prod."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, H., Dong, M., Chen, J., Wang, H., Tenney, K., and Crews, P. (2017). Bioactive Secondary Metabolites from the Marine Sponge Genus Agelas. Mar. Drugs, 15.","DOI":"10.3390\/md15110351"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0041-0101(00)00123-9","article-title":"Membrane permeabilization induced by discodermin A, a novel marine bioactive peptide","volume":"39","author":"Sato","year":"2001","journal-title":"Toxicon"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biotechadv.2015.12.008","article-title":"New marine natural products from sponges (Porifera) of the order Dictyoceratida (2001 to 2012); a promising source for drug discovery, exploration and future prospects","volume":"34","author":"Mehbub","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0040-4039(00)77766-5","article-title":"Manoalide, an antibiotic sesterterpenoid from the marine sponge Luffariella variabilis (polejaeff)","volume":"21","author":"Silva","year":"1980","journal-title":"Tetrahedron Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1039\/np9961300075","article-title":"Marine natural products","volume":"13","author":"Faulkner","year":"1996","journal-title":"Nat. Prod. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Costantino, V., Della Sala, G., Saurav, K., Teta, R., Bar-Shalom, R., Mangoni, A., and Steindler, L. (2017). Plakofuranolactone as a Quorum Quenching Agent from the Indonesian Sponge Plakortis cf. lita. Mar. Drugs, 15.","DOI":"10.3390\/md15030059"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1021\/acs.jnatprod.7b00300","article-title":"Exploring the Sponge Consortium Plakortis symbiotica-Xestospongia deweerdtae as a Potential Source of Antimicrobial Compounds and Probing the Pharmacophore for Antituberculosis Activity of Smenothiazole A by Diverted Total Synthesis","volume":"80","author":"Rode","year":"2017","journal-title":"J. Nat. Prod."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/np900310j","article-title":"Aromatic cyclic peroxides and related keto-compounds from the Plakortis sp. component of a sponge consortium","volume":"72","author":"Manzo","year":"2009","journal-title":"J. Nat. Prod."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13831","DOI":"10.1016\/S0040-4020(99)00866-2","article-title":"Metabolites from the sponge plakortis simplex. II.1: Isolation of four bioactive lactone compounds and of a novel related amino acid","volume":"55","author":"Cafieri","year":"1999","journal-title":"Tetrahedron"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0040-4020(95)00856-X","article-title":"The Plakortones, Novel Bicyclic Lactones from the Sponge Plakortis halichondrioides: Activators of Cardiac SR-Ca2+ -Pumping ATPase","volume":"52","author":"Patil","year":"1996","journal-title":"Tetrahedron"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1021\/np5008944","article-title":"Cytotoxic Plakortides from the Brazilian Marine Sponge Plakortis angulospiculatus","volume":"78","author":"Santos","year":"2015","journal-title":"J. Nat. Prod."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1021\/jo01305a005","article-title":"Metabolites of three marine sponges of the genus Plakortis","volume":"45","author":"Stierle","year":"1980","journal-title":"J. Org. Chem."},{"key":"ref_39","first-page":"62","article-title":"Common Patterns and Unique Threats in Antimicrobial Resistance as Demonstrated by Global Gonococcal Surveillance","volume":"30","author":"Rahman","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Melendez, J.H., Edwards, V.L., Muniz Tirado, A., Hardick, J., Mehta, A., Aluvathingal, J., D\u2019Mello, A., Gaydos, C.A., Manabe, Y.C., and Tettelin, H. (2024). Local emergence and global evolution of Neisseria gonorrhoeae with high-level resistance to azithromycin. Antimicrob. Agents Chemother., e0092724.","DOI":"10.1128\/aac.00927-24"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wi, T., Lahra, M.M., Ndowa, F., Bala, M., Dillon, J.R., Ramon-Pardo, P., Eremin, S.R., Bolan, G., and Unemo, M. (2017). Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002344"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40265-021-01530-0","article-title":"Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions","volume":"81","author":"Lin","year":"2021","journal-title":"Drugs"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hooshiar, M.H., Sholeh, M., Beig, M., Azizian, K., and Kouhsari, E. (2024). Corrigendum: Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: A systematic review and meta-analysis. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1465628"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Varijakzhan, D., Loh, J.Y., Yap, W.S., Yusoff, K., Seboussi, R., Lim, S.E., Lai, K.S., and Chong, C.M. (2021). Bioactive Compounds from Marine Sponges: Fundamentals and Applications. Mar. Drugs, 19.","DOI":"10.3390\/md19050246"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s42452-022-05084-y","article-title":"Secondary plant metabolites as potent drug candidates against antimicrobial-resistant pathogens","volume":"4","author":"Keita","year":"2022","journal-title":"SN Appl. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Amin, M.U., Khurram, M., Khattak, B., and Khan, J. (2015). Antibiotic additive and synergistic action of rutin, morin and quercetin against methicillin resistant Staphylococcus aureus. BMC Complement. Altern. Med., 15.","DOI":"10.1186\/s12906-015-0580-0"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"15274","DOI":"10.1021\/acsomega.1c01590","article-title":"Antigonococcal Activity of (+)-Medicarpin","volume":"6","author":"Williams","year":"2021","journal-title":"ACS Omega"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/np300771p","article-title":"Cytotoxic polyketide derivatives from the South China Sea sponge Plakortis simplex","volume":"76","author":"Zhang","year":"2013","journal-title":"J. Nat. Prod."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.02.054","article-title":"Clerodane type diterpene as a novel antifungal agent from Polyalthia longifolia var. pendula","volume":"94","author":"Bhattacharya","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mazur, M., and Maslowiec, D. (2022). Antimicrobial Activity of Lactones. Antibiotics, 11.","DOI":"10.3390\/antibiotics11101327"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/12\/1229\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:34Z","timestamp":1760115334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/12\/1229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["antibiotics13121229"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics13121229","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}